FDA questions whether pharma company provided accurate data about Zyprexa’s side effects

The FDA is looking into whether Eli Lilly & Company, a pharmaceutical company, provided it with accurate data about the side effects of the antipsychotic drug Zyprexa. The drug has been linked to weight gain and diabetes and has been the subject of numerous lawsuits. The FDA is questioning in particular a document from February 2000 where the company found the patients taking Zyprexa were three and a half times as likely to develop high blood sugar as those who did not. The FDA did not receive that document. However, a few months later, Lilly gave data to the FDA that showed very little difference in blood sugar between patients taking the drug and those not taking the drug.

For the full article.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers